EDUCATIONAL OBJECTIVES
After attending this activity, the participant will demonstrate the ability to:
  • Apply new information on the pathogenesis of HIV and liver disease in management strategies.
  • Identify antiretroviral and HBV/HCV antiviral therapies based upon the most recent USPHS, IAS-USA, AASLD, IDSA and EASL Guidelines.
  • Evaluate patients with antiretroviral and/or liver therapy failure based upon the most recent data presented at the previous EASL, CROI, AASLD, HIV Glasgow, IAC, ICAAC, IDWeek, and EACS conferences.
  • Manage antiviral (HIV, HBV, HCV) drug interactions, side effects, and complications of treatment incorporating the latest pharmacogenomics/kinetics/dynamics data.
  • Evaluate patients for pre-exposure prophylaxis therapy to prevent HIV infection.
  • Identify management strategies of sexually transmitted infections in patients with HIV or hepatitis.

AGENDA

 

 Saturday, March 26, 2022

 

 07:00 AM – 08:00 AM Breakfast  

 

 08:00 AM – 08:10 AM Introduction and Conference Goals Michael S. Saag, MD

 

 08:10 AM – 08:35 AM Antiretroviral Therapy: Starts, Switches and Rescues – Where Are We Now? Joseph J. Eron Jr., MD

 

 08:35 AM – 09:00 AM New Drugs for HIV Connie Benson, MD

 

 09:00 AM – 09:20 AM Panel Discussion / Questions and Answers  

 

 09:20 AM – 09:45 AM Post-Conference Update from CROI 2022 Rajesh T. Gandhi, MD

 

 09:45 AM – 10:00 AM Break  

 

 10:00 AM – 10:25 AM Hot Topics in Pharmacology: Drug Interactions Charles W. Flexner, MD

 

 10:25 AM – 10:45 AM Panel Discussion / Questions and Answers  

 

 10:45 AM – 11:10 AM Update on Sexually Transmitted Infections Jeanne Marrazzo, MD

 

 11:10 AM – 11:35 AM Pre-exposure Prophylaxis for HIV Infection Ronnie M. Gravett, MD

 

 11:35 AM – 11:55 AM Panel Discussion / Questions and Answers  

 

 11:55 AM – 12:20 PM Considerations for Patients with Substance Abuse Glenn J. Treisman, MD, PhD

 

 12:20 PM – 12:30 PM Panel Discussion / Questions and Answers  

 

 12:30 PM – 12:45 PM Break  

 

 12:45 PM – 01:45 PM Working Lunch - Case Presentations   Michael S. Saag, MD and faculty panel

 

 01:50 PM – 02:20 PM Faculty Roundtable Session 1*  

 

 02:25 PM – 02:55 PM Faculty Roundtable Session 2*
(In-person attendees will have the opportunity to attend two of the four sessions)
PrEP and Prevention: Therapeutics and Behavior Jeanne Marrazzo, MD
Ronnie M. Gravett, MD
Antiretroviral Therapy: Emerging Issues and Challenging Cases Rajesh T. Gandhi, MD
Charles Flexner, MD
Advances in HIV Treatment Joseph J. Eron, Jr., MD
Connie Benson, MD
Early Management of COVID-19 Michael S. Saag, MD
Glenn J. Treisman, MD, PhD

 

 Sunday, March 27, 2022

 

 07:00 AM – 08:00 AM Breakfast  

 

 08:00 AM – 08:10 AM Introduction and Conference Goals Mark S. Sulkowski, MD

 

 08:10 AM – 08:35 AM Management Considerations for Hepatitis C Susanna Naggie, MD, MHS

 

 08:35 AM – 09:00 AM Reinfection and Cancer after Hepatitis C Cure Arthur Y. Kim, MD

 

 09:00 AM – 09:20 AM Panel Discussion / Questions and Answers  

 

 09:20 AM – 09:45 AM Management Considerations for Hepatitis B Chloe L. Thio, MD

 

 09:45 AM – 10:10 AM Hepatitis B Cure: New Drugs, Novel Strategies Jordan Feld, MD, MPH

 

 10:10 AM – 10:30 AM Panel Discussion / Questions and Answers  

 

 10:30 AM – 10:45 AM Break  

 

 10:45 AM – 11:10 AM Approaches to Persons with HIV and Elevated Liver Enzymes Kenneth E. Sherman, MD

 

 11:10 AM – 11:35 AM Fatty Liver Disease in Persons With HIV E. Turner Overton, MD

 

 11:35 AM – 11:55 AM Panel Discussion / Questions and Answers  

 

 11:55 AM – 12:10 PM Break  

 

 12:10 PM – 01:10 PM Working Lunch - Case Presentations Mark S. Sulkowski, MD and faculty panel

 

 01:15 PM – 01:45 PM Faculty Roundtable Session 1*  

 

 01:50 PM – 02:20 PM Faculty Roundtable Session 2*
(In-person attendees will have the opportunity to attend two of the four sessions)
Hepatitis C: Challenging Cases Susanna Naggie, MD, MHS
Arthur Y. Kim, MD
Hepatitis B and D: More Questions and Answers Chloe Thio, MD
Jordan Feld, MD, MPH
Fatty Liver Disease E. Turner Overton, MD
Kenneth E. Sherman, MD

 

* Faculty Roundtable sessions are only available for in-person conference participants. These sessions will not be available for virtual participants.

The schedule of events and faculty are subject to change.


Rush Logo

This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications.

Practice Point Communications and Rush University Medical Center do not share your name or contact information with any other party.